HopeStage
Back to all studies
CompletedNCT02870283

Treatment Options and Quality of Life During Mixed Mood Episodes in Bipolarity

About this titleRead the official source — NCT02870283
Medication studyAges 18–65
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 65 years.

Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateMay 2010
Recruitment status
Completed
Enrollment listed in the registry
107
Sponsor
Federal University of Rio Grande do Sul
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
Not clearly listed
Age range
From 18 Years to 65 Years
Official registry ID
NCT02870283
Official title
Show the full official title

Assessment of Cost- Effectiveness Interventions and the Quality of Life in Patients With Mood Disorders Through Resources Available in Brazilian Public Health

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Locations not listed

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Federal University of Rio Grande do Sul, a university.

Did this study involve medication?

Yes. The study involved medication, including lithium, Valproic Acid and Carbamazepine.

Who was this study for?

Listed age limits: 18 years to 65 years.

Want to explore more studies?

Explore studies